Savara

$1.95
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.09 (-4.41%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell Savara and other stocks, options, and ETFs commission-free!

About SVRA

Savara Inc. Common Stock, also called Savara, is a clinical-stage pharmaceutical company, which engages in the development and commercialization of novel therapies for the treatment of serious or life-threatening rare respiratory diseases.

CEO
Matthew Pauls
Employees
27
Headquarters
Austin, Texas
Founded
2017
Market Cap
219.98M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
4.15M
High Today
$2.01
Low Today
$1.91
Open Price
$2.00
Volume
1.31M
52 Week High
$3.58
52 Week Low
$0.9952

SVRA Earnings

-$0.41
-$0.27
-$0.14
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 6

You May Also Like

BBQ
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure